Concepedia

Kathrin Michel

KM

13

Publications

5.5K

Citations

13

H-Index

2003

Active since

Affiliations

Max Planck Institute for Metabolism Research(Current)

Max Planck Society

Harvard University

University of Cologne

Chemical Genomics Centre

Kathrin Michel is an author at Max Planck Institute for Metabolism Research specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyOncologyCancer BiologyPlant PathologySystems BiologyRadiation OncologyEngineeringLung Cancer

Publications per year

2003–2024

13

Publications

13

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie, Pablo Tamayo, Jesse S. Boehm et al. · Nature · 2009 · 4.1K citations · Full text

Systems Biology, Oncogenic Agent, Medicine +4

<i>PTEN</i> Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Martin L. Sos, Mirjam Koker, Barbara A. Weir et al. · Cancer Research · 2009 · 492 citations · Full text

Egfr-mutant Lung Cancer, Pten Loss, Cancer Biology +16

Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions

Martin L. Sos, Kathrin Michel, Thomas Zander et al. · Journal of Clinical Investigation · 2009 · 262 citations · Full text

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

Martin L. Sos, Stefanie Fischer, Roland T. Ullrich et al. · Proceedings of the National Academy of Sciences · 2009 · 255 citations · Full text

Cancer Biology, Tumor Biology, Oncology +18

Novel <i>MEK1</i> Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma

Jenifer L. Marks, Yixuan Gong, Dhananjay Chitale et al. · Cancer Research · 2008 · 207 citations · Full text

Rows per page

1–5 of 13